tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Progyny price target raised to $25 from $21 at BofA

BofA analyst Allen Lutz raised the firm’s price target on Progyny (PGNY) to $25 from $21 and keeps a Buy rating on the shares. The firm argues that the set-up for Progyny is “much better in 2025” as Street expectations have been reset while shares trade at the low end of the company’s historic multiple range. If Progyny can execute in 2025, the firm sees the potential for multiple expansion over the course of the year, adds the analyst, who raised the multiple the firm applies to its estimates to reflect incremental confidence in execution.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1